The 2025 edition of the EdelGive Hurun list recognizes 24 exceptional women leaders for their philanthropic impact across critical areas
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
The antibody was designed and developed at Abzena’s Cambridge, UK,
The event will be attended by 35,000+ industry professionals
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
Upgrades 2025 full-year CDMO sales and margin outlook
Subscribe To Our Newsletter & Stay Updated
